Company · CIK 0001690585 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Dianthus Therapeutics, Inc. /DE/ · DNTH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $101.38 | $2,027,646 | 0 | −100% | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $17.88 | $357,600 | 20,000 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $106.41 | $2,460,690 | 4,000 | −85.3% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $20.63 | $477,047 | 27,124 | — | 10b5-1 |
| Aug 19, 2026 SForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | $117.55 | $326,554 | 0 | −100% | 10b5-1 |
| Aug 19, 2026 MForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | $18.36 | $51,004 | 2,778 | — | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 15,000 | $18.17 | $272,550 | 15,000 | — | |
| Aug 10, 2026 SForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | $109.01 | $844,822 | 0 | −100% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | $12.52 | $97,000 | 7,750 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | $109.55 | $304,232 | 0 | −100% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | $18.36 | $50,986 | 2,777 | — | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | $110.44 | $2,208,833 | 0 | −100% | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | $17.88 | $357,600 | 16,167 | — | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | $108.11 | $17,945,451 | 65,292 | −71.8% | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | $8.44 | $1,401,040 | 231,292 | — | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | $101.03 | $3,157,151 | 0 | −100% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | $21.77 | $680,291 | 31,249 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | $80.80 | $2,423,958 | 0 | −100% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | $17.88 | $536,400 | 30,000 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | — | — | 43,818 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | — | — | 87,500 | — | 10b5-1 |
| Aug 19, 2026 MForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | — | — | 19,445 | — | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 15,000 | — | — | 73,240 | — | |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | — | — | 0 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | — | — | 22,223 | — | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | — | — | 60,000 | — | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | — | — | 160,004 | — | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | — | — | 68,751 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | — | — | 80,000 | — | 10b5-1 |